Back
Published On

Multimodality Treatment in Case of Peritoneal Mesothelioma – A Case Report and Review of Literature

Abstract

Peritoneal mesothelioma (PeM) represents around one fifth to one third of all mesothelioma. The incidence of PeM is approximately one per 1,000,000. Giving the fact of non-specificity of the symptoms, the diagnoses is usually delay. Multimodality treatment with adjuvant chemotherapy and cytoreductive surgery (CRS) and hyper thermic intraperitoneal chemotherapy (HIPEC) improve the long term survival. Herein, this is a presentation of patient diagnosed with peritoneal mesothelioma with a review of literature.

Keywords

Chemotherapy, cytoreductive surgery, peritoneal mesothelioma

  • License

    Creative Commons Attribution 4.0 (CC BY 4.0)

  • Language & Pages

    English, 15-18

  • Classification

    NLMC CODE: QY 210

Next Research
Copy of Cardiovascular Risk Factors and Cardiovascular Risk in People Living with HIV: Comparison of Four Cardiovascular Risk Prediction Algorithms